TY - JOUR
T1 - Handling of allergen immunotherapy in the COVID-19 pandemic
T2 - An ARIA-EAACI statement
AU - ARIA-MASK study group
AU - Klimek, Ludger
AU - Jutel, Marek
AU - Akdis, Cezmi
AU - Bousquet, Jean
AU - Akdis, Mübeccel
AU - Bachert, Claus
AU - Agache, Ioana
AU - Ansotegui, Ignacio
AU - Bedbrook, Anna
AU - Bosnic-Anticevich, Sinthia
AU - Canonica, Giorgio W
AU - Chivato, Tomas
AU - Cruz, Alvaro A
AU - Czarlewski, Wiencyslawa
AU - Giacco, Stefano Del
AU - Du, Hui
AU - Fonseca, Joao A
AU - Gao, Yadong
AU - Haahtela, Tari
AU - Hoffmann-Sommergruber, Karin
AU - Ivancevich, Juan-Carlos
AU - Khaltaev, Nikolai
AU - Knol, Edward F
AU - Kuna, Piotr
AU - Larenas-Linnemann, Desiree
AU - Melen, Erik
AU - Mullol, Joaquim
AU - Naclerio, Robert
AU - Ohta, Ken
AU - Okamoto, Yoshitaka
AU - O'Mahony, Liam
AU - Onorato, Gabrielle L
AU - Papadopoulos, Nikos G
AU - Pawankar, Ruby
AU - Pfaar, Oliver
AU - Samolinski, Boleslaw
AU - Schwarze, Jurgen
AU - Toppila-Salmi, Sanna
AU - Shamji, Mohamed H
AU - Ventura, Maria Teresa
AU - Valiulis, Arunas
AU - Yorgancioglu, Arzu
AU - Matricardi, Paolo
AU - Zuberbier, Torsten
N1 - This article is protected by copyright. All rights reserved.
PY - 2020/4/24
Y1 - 2020/4/24
N2 - The current COVID-19 pandemic influences many areas of social life, medical treatments and the way allergy is performed. Allergen-specific immunotherapy (AIT) is one of the most important treatment options for IgE-mediated allergies and is based on immunological effects on the diseased patient.
AB - The current COVID-19 pandemic influences many areas of social life, medical treatments and the way allergy is performed. Allergen-specific immunotherapy (AIT) is one of the most important treatment options for IgE-mediated allergies and is based on immunological effects on the diseased patient.
U2 - 10.1111/all.14336
DO - 10.1111/all.14336
M3 - Article
C2 - 32329930
SN - 0105-4538
JO - Allergy
JF - Allergy
ER -